Summary of Key Information:
Reporting Period: Quarter ended June 30, 2026
Nature of Filing / Announcement: Quarterly financial results submission to stock exchanges
Audit Opinion:
Limited review report issued by statutory auditors - No qualifications or modifications noted. Clean review opinion.
Key Financial Highlights [All amounts in Rs. Lakhs]:
Consolidated Results:
Revenue from Operations: ₹5,191.13 (QoQ: +5.0% from ₹4,943.34 in Q4 FY26; YoY: -0.9% from ₹5,147.38 in Q1 FY26)
Other Income: ₹2,816.53 (QoQ: +33.1% from ₹2,115.41)
Total Income: ₹8,007.66 (QoQ: +13.4% from ₹7,058.75)
Expenses:
- Employee benefits expense: ₹1,101.20 (QoQ: +0.2% from ₹1,099.50)
- Finance costs: ₹1,672.81 (QoQ: +3.3% from ₹1,619.25)
- Depreciation and amortisation: ₹817.18 (QoQ: +3.0% from ₹793.17)
- Advertisement and Sales promotion: ₹1,981.30 (QoQ: -18.3% from ₹2,426.16)
- Other expenses: ₹504.19 (QoQ: -46.5% from ₹942.62)
Total Expenses: ₹6,868.88 (QoQ: -10.5% from ₹7,675.92)
Profit/(Loss) before tax: ₹1,138.78 (vs. loss of ₹617.17 in Q4 FY26)
Tax expenses: ₹303.46
Profit for the period: ₹835.32 (vs. loss of ₹408.00 in Q4 FY26)
EPS: Basic ₹0.51, Diluted ₹0.51 (not annualized)
Paid up equity share capital: ₹16,349.24 (Face value ₹10 per share)
Standalone Results:
Revenue from Operations: ₹1,884.25 (QoQ: +32.6% from ₹1,421.17)
Other Income: ₹2,740.25 (QoQ: +0.2% from ₹2,734.68)
Total Income: ₹4,624.50 (QoQ: +11.3% from ₹4,155.85)
Expenses:
- Employee benefits expense: ₹1,266.00 (QoQ: +17.1% from ₹1,080.92)
- Finance costs: ₹292.08 (QoQ: +56.8% from ₹186.30)
- Depreciation and amortisation: ₹181.58 (QoQ: -1.8% from ₹184.83)
- Other expenses: ₹1,023.81 (QoQ: -0.9% from ₹1,033.46)
Total Expenses: ₹2,763.47 (QoQ: +11.2% from ₹2,485.51)
Profit before tax: ₹1,861.03 (QoQ: +11.4% from ₹1,670.34)
Tax expense: ₹647.69
Profit for the period: ₹1,213.34 (QoQ: +52.4% from ₹796.30)
EPS: Basic ₹0.74, Diluted ₹0.74 (not annualized)
Paid up equity share capital: ₹16,349.24 (Face value ₹10 per share)
Other Equity: ₹2,38,991.41
Segment-wise Performance:
The Group operates in a single reportable segment - real estate development. No additional segment disclosures required under Ind AS 108.
Corporate Actions:
ESOP Activity (Consolidated):
- Options granted during quarter: 2,71,666
- Shares issued against exercised options: 51,787
ESOP Activity (Standalone):
- Options granted during quarter: 2,71,666
- Shares issued against exercised options: 51,787
- Shares forfeited: 564
Other Significant Information:
Subsidiaries included in consolidation: 14 entities including Max Towers Private Limited, Max Assets Services Limited, Max Square Limited, Pharmax Corporation Limited, and others.
QIP Proceeds Utilization (as of date):
- Acquisition of land/development rights: ₹64,606.00 lakhs utilized of ₹65,000.00 lakhs
- General corporate purpose: ₹12,957.55 lakhs fully utilized
- Total utilized: ₹79,605.55 lakhs of ₹79,999.55 lakhs received
Warrant Allotment Details (October 29, 2024):
- Max Ventures Investment Holding Private Limited (Promoter): 11,41,552 warrants at ₹657 each
- Mr. Sunil Vachani (Public): 11,41,552 warrants at ₹657 each
- Entire amount of ₹15,000 lakhs received and equity shares allotted